Tetra Radar · FDA Approvals · Decision date
nimodipine: FDA decision date
Grace Therapeutics Inc (GRCE) · 23 April 2026
On August 22, 2025 the FDA accepted our NDA for review and established April 23, 2026 as the Prescription Drug User Fee Act (PDUFA) target date for completing its review of our submission.
Source: 10-Q of 12 February 2026
The date has passed; Tetra Radar has not recorded an approval.
Grace Therapeutics Inc on Tetra Radar
A PDUFA date is the date by which the FDA has said it will decide on an application. Dates can move, and a decision is not an approval. Tetra Radar observes public information for research purposes. It does not provide investment advice.